Anlon Healthcare
AHCL · Pharma > Pharmaceuticals & Drugs Listing date: Sept. 3, 2025

Stock Price vs Company Growth
1d
4.8%
1w
6.9%
1m
3.5%
3m
21.1%
all
69.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 155 4.8%
117
172
Company Overview

Sales
147 Cr
Growth: -19.9%
Profit after Tax
19.2 Cr
Growth: 40.6%
Small Cap
824 Cr
P/E: 29.5x
Industry P/E: 33.1x
Fundamentals

Sales (Cr) ₹ 147
Growth -19.9%
EBITDA 23.3%
P/S 5.6x
Dividend 0.0%
P/E 29.5x
Book Value ₹ 10
PEG Ratio -1.5x
ROE 51.6%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets. Its products span across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
Belongs to (2 Indices)